NO324251B1 - <Beta>-karbolinderivater, farmasoytisk preparat inneholdende samme, fremgangsmate for fremstilling av farmasoytisk preparat ved anvendelse av beta-karbolinderivater for fremstilling av medikament - Google Patents

<Beta>-karbolinderivater, farmasoytisk preparat inneholdende samme, fremgangsmate for fremstilling av farmasoytisk preparat ved anvendelse av beta-karbolinderivater for fremstilling av medikament

Info

Publication number
NO324251B1
NO324251B1 NO20025527A NO20025527A NO324251B1 NO 324251 B1 NO324251 B1 NO 324251B1 NO 20025527 A NO20025527 A NO 20025527A NO 20025527 A NO20025527 A NO 20025527A NO 324251 B1 NO324251 B1 NO 324251B1
Authority
NO
Norway
Prior art keywords
preparation
beta
carboline derivatives
pharmaceutical preparation
drugs
Prior art date
Application number
NO20025527A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025527D0 (no
NO20025527L (no
Inventor
Mark J Macielag
Zhihua Sui
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20025527D0 publication Critical patent/NO20025527D0/no
Publication of NO20025527L publication Critical patent/NO20025527L/no
Publication of NO324251B1 publication Critical patent/NO324251B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
NO20025527A 2000-05-17 2002-11-18 <Beta>-karbolinderivater, farmasoytisk preparat inneholdende samme, fremgangsmate for fremstilling av farmasoytisk preparat ved anvendelse av beta-karbolinderivater for fremstilling av medikament NO324251B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20466700P 2000-05-17 2000-05-17
PCT/US2001/014357 WO2001087038A2 (fr) 2000-05-17 2001-05-03 Derives $g(b)-carboline utiles en tant qu'inhibiteurs de la phosphodiesterase

Publications (3)

Publication Number Publication Date
NO20025527D0 NO20025527D0 (no) 2002-11-18
NO20025527L NO20025527L (no) 2003-01-16
NO324251B1 true NO324251B1 (no) 2007-09-17

Family

ID=22758909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025527A NO324251B1 (no) 2000-05-17 2002-11-18 <Beta>-karbolinderivater, farmasoytisk preparat inneholdende samme, fremgangsmate for fremstilling av farmasoytisk preparat ved anvendelse av beta-karbolinderivater for fremstilling av medikament

Country Status (32)

Country Link
US (2) US6492358B2 (fr)
EP (1) EP1289985B1 (fr)
JP (1) JP5014551B2 (fr)
KR (1) KR20030031482A (fr)
CN (1) CN1255403C (fr)
AR (1) AR028576A1 (fr)
AT (1) ATE256127T1 (fr)
AU (2) AU2001261167B2 (fr)
BG (1) BG66141B1 (fr)
CA (1) CA2409715C (fr)
CZ (1) CZ20023934A3 (fr)
DE (1) DE60101479T2 (fr)
DK (1) DK1289985T3 (fr)
ES (1) ES2211806T3 (fr)
GE (1) GEP20053511B (fr)
HK (1) HK1051368A1 (fr)
HR (1) HRP20020910B1 (fr)
HU (1) HUP0302412A3 (fr)
IL (2) IL152873A0 (fr)
MX (1) MXPA02011426A (fr)
MY (1) MY128479A (fr)
NO (1) NO324251B1 (fr)
NZ (1) NZ522731A (fr)
PL (1) PL205507B1 (fr)
PT (1) PT1289985E (fr)
RU (1) RU2271358C2 (fr)
SK (1) SK16972002A3 (fr)
TR (1) TR200302309T4 (fr)
TW (1) TWI286553B (fr)
UA (1) UA74826C2 (fr)
WO (1) WO2001087038A2 (fr)
ZA (1) ZA200210111B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1347759B1 (fr) * 2000-12-08 2005-06-29 Smithkline Beecham Corporation Composes antibacteriens
US6900220B2 (en) * 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
EP1360185B1 (fr) * 2001-02-12 2005-08-24 Lilly Icos LLC Derives de carboline
WO2002064591A2 (fr) * 2001-02-12 2002-08-22 Lilly Icos Llc Composes chimiques
CA2441792C (fr) * 2001-04-25 2010-08-03 Lilly Icos Llc Derives de carboline utilises comme inhibiteurs de phosphodiesterase 5 (pdes) dans le traitement de maladies cardiovasculaires et du dysfonctionnement erectile
JP2004536816A (ja) 2001-06-05 2004-12-09 リリー アイコス リミテッド ライアビリティ カンパニー Ｐｄｅ５阻害剤としてのカルボリン誘導体
EP1397361B1 (fr) * 2001-06-21 2006-08-09 Lilly Icos LLC Derives de carboline en tant qu'inhibiteurs de pdev
DK1448562T3 (da) 2001-11-14 2007-09-24 Ortho Mcneil Pharmaceutical Co Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer
BRPI0307699A2 (pt) * 2002-02-07 2015-06-16 Gtx Inc Tratamento de hiperplasia benigna da próstata com sarms.
EP1534707B9 (fr) * 2002-06-19 2008-11-26 Janssen Pharmaceutica N.V. Derives substitues de 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one utilises comme inhibiteurs de la phosphodiesterase
WO2004113300A1 (fr) * 2003-06-23 2004-12-29 Ono Pharmaceutical Co., Ltd. Nouveau compose heterocyclique tricyclique
EP1706404A2 (fr) 2004-01-23 2006-10-04 Chiron Corporation Composes de tetrahydrocarboline comme agents anticancereux
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
EP1737461B1 (fr) * 2004-03-15 2012-12-12 PTC Therapeutics, Inc. Derives de carboline utiles dans l'inhibition de l'angiogenese
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
EP1829874B1 (fr) * 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Compose tricyclique et son utilisation
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
EP2324886A1 (fr) * 2005-07-29 2011-05-25 Concert Pharmaceuticals Inc. Nouveaux analogues deutériés de tadalafil
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (fr) 2005-10-31 2007-05-10 Braincells, Inc. Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (fr) 2006-05-09 2011-10-19 Braincells, Inc. Neurogénèse par modulation de l'angiotensine
EP2026813A2 (fr) 2006-05-09 2009-02-25 Braincells, Inc. Neurogenèse induite par le récepteur 5ht
US7998971B2 (en) * 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CA2693214A1 (fr) * 2007-07-19 2009-01-22 Merck Sharp & Dohme Corp. Derives de beta-carboline en tant que composes antidiabetiques
WO2009073534A2 (fr) 2007-11-30 2009-06-11 Maxthera Inc. Inhibiteurs de ppat bicycliques utilisés en tant qu'agents antibactériens
AU2009204048B2 (en) 2008-01-11 2013-08-01 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as MCH antagonists
BRPI0906244A2 (pt) 2008-03-24 2015-06-30 Medivation Technologies Inc Composto, composição farmacêutica, método para tratar um distúrbio cognitivo, psicótico, mediado por neurotransmissores ou um distúrbio neuronal em um indivíduo, uso de um composto e kit
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20120135089A1 (en) * 2009-03-17 2012-05-31 Stockwell Brent R E3 ligase inhibitors
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8629158B2 (en) 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8637501B2 (en) 2009-07-01 2014-01-28 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof
WO2011003012A1 (fr) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Antagonistes de mch-1 azapolycycles substitués par azinone, leurs procédés de fabrication et leur utilisation
US20130137705A1 (en) * 2009-09-23 2013-05-30 Sarvajit Chakravarty Pyrido[3,4-b]indoles and methods of use
NZ603575A (en) * 2010-07-06 2014-03-28 Ono Pharmaceutical Co Tetrahydrocarboline derivative
WO2012088038A2 (fr) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Antagonistes de mch-1 consistant en tétrahydro-carbolines substituées par pipérazinone, leurs procédés de fabrication et utilisations
WO2012088124A2 (fr) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Antagonistes de la mch-1 à base de tétrahydro-azacarboline, leurs procédés de fabrication et leurs utilisations
TW201309698A (zh) 2011-03-18 2013-03-01 Ono Pharmaceutical Co 四氫咔啉衍生物
EP2804603A1 (fr) 2012-01-10 2014-11-26 President and Fellows of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
WO2017168174A1 (fr) 2016-04-02 2017-10-05 N4 Pharma Uk Limited Nouvelles formes pharmaceutiques du sildénafil
CN107216327A (zh) * 2017-06-27 2017-09-29 山东大学 5型磷酸二酯酶抑制剂及其制备方法和用途
WO2021046194A1 (fr) * 2019-09-03 2021-03-11 The Regents Of The University Of Colorado A Body Corporate Benzothiazoles à base de tryptoline et leur utilisation en tant qu'antibiotiques et agents modifiant la résistance aux antibiotiques
WO2022140744A1 (fr) 2020-12-23 2022-06-30 Recurium Ip Holdings, Llc Modulateurs du récepteur des œstrogènes

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055203A (en) 1964-09-16 1967-01-18 Ici Ltd -ß-carboline derivatives, a process for their manufacture, and compositions containing them
US4228168A (en) 1978-11-22 1980-10-14 Tanabe Seiyaku Co., Ltd. Azepino [1,2,3-lm]-β-carboline compounds and pharmaceutical composition thereof
NZ194747A (en) 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
DE3752373T2 (de) 1986-10-13 2004-03-25 Asahi Kasei Kogyo K.K. Pyridin-derivate
CS262100B1 (cs) * 1987-07-17 1989-02-10 Protiva Miroslav 1-substituované 2- [ (4-methyl-l-piperazinyl)acetyl ] -2,3,4,9- -tetrahydro-lH-pyrido( 3,4-b)indoly a jejich hydrochloridy
DE3855147D1 (de) 1987-07-20 1996-05-02 Duphar Int Res 8,9-Anellierte 1,2,3,4-Tetrahydro-beta-carbolin-Derivate
FR2619112B1 (fr) * 1987-08-07 1989-11-17 Synthelabo Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique
US4971974A (en) 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
EP0386258A4 (en) 1988-08-11 1992-05-13 Asahi Kasei Kogyo Kabushiki Kaisha Tetrahydropyridine derivatives
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
FR2663935A1 (fr) 1990-06-27 1992-01-03 Adir Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
US5403851A (en) 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
ATE247114T1 (de) * 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
FR2724384B1 (fr) 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament
DE4436190A1 (de) 1994-10-10 1996-04-11 Gerhard Prof Dr Bringmann Halogenierte ß-Carbolin-Derivate, Verfahren zu ihrer Herstellung und Verwendung dieser Substanzen zur Hemmung der Atmungskette
DE4436509A1 (de) 1994-10-13 1996-04-18 Hoechst Schering Agrevo Gmbh Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US5968910A (en) * 1994-11-30 1999-10-19 Jan M. R. Balzarini Compositions containing two or three inhibitors of different HIV reverse transcriptases
GB9514464D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
FR2748026B1 (fr) 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP3418405B2 (ja) 1996-05-10 2003-06-23 アイコス コーポレイション カルボリン誘導体
US6018046A (en) 1996-05-31 2000-01-25 Mochida Pharmaceutical Co., Ltd. Pyridocarbazole derivatives having cGMP-PDE inhibitory activity
AU6290998A (en) 1997-03-07 1998-09-29 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno{3,2-c}pyridine derivatives, their preparation and use
US6043252A (en) 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
AU4919099A (en) 1998-07-11 2000-02-01 University Of Bristol, The Compounds having activity at imidazoline receptors
FR2796644B1 (fr) * 1999-07-23 2001-09-07 Adir Nouveaux derives de beta-carboline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
US6864253B2 (en) 2005-03-08
UA74826C2 (en) 2006-02-15
US20030166641A1 (en) 2003-09-04
US6492358B2 (en) 2002-12-10
CA2409715A1 (fr) 2001-11-22
NO20025527D0 (no) 2002-11-18
CN1255403C (zh) 2006-05-10
BG66141B1 (bg) 2011-07-29
ATE256127T1 (de) 2003-12-15
AU6116701A (en) 2001-11-26
AR028576A1 (es) 2003-05-14
WO2001087038A2 (fr) 2001-11-22
EP1289985B1 (fr) 2003-12-10
NO20025527L (no) 2003-01-16
NZ522731A (en) 2004-09-24
CA2409715C (fr) 2010-09-14
JP2003533453A (ja) 2003-11-11
PL205507B1 (pl) 2010-04-30
IL152873A (en) 2012-01-31
DE60101479D1 (en) 2004-01-22
BG107285A (bg) 2003-07-31
SK16972002A3 (sk) 2003-11-04
US20020010189A1 (en) 2002-01-24
PL365445A1 (en) 2005-01-10
AU2001261167B2 (en) 2006-10-05
DK1289985T3 (da) 2004-04-05
ZA200210111B (en) 2004-03-12
KR20030031482A (ko) 2003-04-21
HUP0302412A3 (en) 2007-02-28
MY128479A (en) 2007-02-28
HRP20020910A2 (en) 2004-12-31
WO2001087038A3 (fr) 2002-05-16
GEP20053511B (en) 2005-05-10
MXPA02011426A (es) 2004-09-06
ES2211806T3 (es) 2004-07-16
CN1446217A (zh) 2003-10-01
PT1289985E (pt) 2004-03-31
CZ20023934A3 (cs) 2003-10-15
TR200302309T4 (tr) 2004-02-23
JP5014551B2 (ja) 2012-08-29
IL152873A0 (en) 2003-06-24
RU2271358C2 (ru) 2006-03-10
DE60101479T2 (de) 2005-04-28
HUP0302412A2 (hu) 2003-11-28
HRP20020910B1 (en) 2011-02-28
HK1051368A1 (en) 2003-08-01
EP1289985A2 (fr) 2003-03-12
TWI286553B (en) 2007-09-11

Similar Documents

Publication Publication Date Title
NO324251B1 (no) &lt;Beta&gt;-karbolinderivater, farmasoytisk preparat inneholdende samme, fremgangsmate for fremstilling av farmasoytisk preparat ved anvendelse av beta-karbolinderivater for fremstilling av medikament
NO20032734D0 (no) Nye 1,2-difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder nevnte forbindelser og anvendelse avdisse for behandling av sykdommer fra lipidstoffskiftet
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
NO20031692L (no) Fremgangsmåte for fremstilling av pulverformuleringer
EE04915B1 (et) Kinuklidiinderivaadid, nende valmistamismeetod, vahehendid, farmatseutiline kompositsioon ja nende kasutamine
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
HUP0300157A3 (en) Anti-inflammatory and analgesic heterocyclo-alkylsulfonyl pyrazole derivatives, process for their preparation and pharmaceutical compounds containing them
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
DE60301570D1 (de) 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
HUP0301075A3 (en) Diphenyl ether derivatives, their use for preparation of pharmaceutical compositions and process for preparation the compounds
AU2002341241A1 (en) Process for the preparation of fast dissolving dosage form
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
EE200100706A (et) A-grupi streptogramiinide derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon
HUP0400317A3 (en) Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
NO20005000D0 (no) FremgangsmÕte for fremstilling av rÕstoffer for glassfremstilling
NO20021368L (no) Fremgangsmåte for fremstilling av fenyleddiksyre derivater
NO20004638D0 (no) Hypnotisk &lt;beta&gt;-karbolinderivater, fremgangsmÕte til deres fremstilling og deres anvendelse som legemiddelprodukt
EE200100711A (et) Naftüridiini derivaadid, nende valmistamismeetod ning neid sisaldav farmatseutiline kompositsioon
HUP0301784A3 (en) Biphenyl derivatives, of imidazole and benzimidazole the use thereof, process for the preparation of compounds and pharmaceutical compositions containing them
NO20012518D0 (no) Fremgangsmåte ved fremstilling av legemidler i fast administrasjonsform
HUP0301008A3 (en) New imidazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees